Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

J Gen Intern Med. 2023 Dec;38(16):3640-3643. doi: 10.1007/s11606-020-06198-y. Epub 2020 Sep 15.

Authors

Mark K Meiselbach¹, Ge Bai^{2

3}, Gerard F Anderson^{1

4}

Affiliations

¹ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
² Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. gbai@jhu.edu.
³ Johns Hopkins Carey Business School, Baltimore, MD, USA. gbai@jhu.edu.
⁴ Johns Hopkins School of Medicine, Baltimore, MD, USA.

PMID: 32935319
PMCID: PMC7491868 (available on 2024-12-01)
DOI: 10.1007/s11606-020-06198-y

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Testing*
COVID-19* / diagnosis
Humans

Grants and funding

T32 HS000029/HS/AHRQ HHS/United States